Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Confident But Cautious On Alzheimer's Hopeful

Key Gantenerumab Readout Next Year

Feb 08 2021

• By Kevin Grogan

Roche closely monitoring Alzheimer's space • Source: Archive

Related Content

Vaccinex Sees Mixed Signals In Huntington’s Study

Sep 22 2020

Novartis Takes Huntington's Path With SMA Therapy Branaplam

Oct 23 2020

Open-Label Extensions The Key To Gantenerumab Success, Stresses Roche

Apr 26 2019

Roche Continues To Make The Case For Gantenerumab In Alzheimer’s Disease

Dec 07 2019

An Alzheimer’s Win: How Lilly Designed Donanemab Trial To Succeed

Jan 13 2021

Related Companies

Roche Holding AG

Biogen, Inc.

Eli Lilly and Company

Ionis Pharmaceuticals, Inc.

Neurocrine Biosciences, Inc.

CervoMed, Inc.

AOP Orphan Pharmaceuticals AG

Vaccinex, Inc.

Novartis AG

uniQure N.V.

Additional Topics

Clinical Trials Strategy Research & Development Neurology BioPharmaceutical

More from Neurological

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window